Navigation Links
Novare Announces Completion of First Pediatric Single Port Spleen Removal Using RealHand(R) HD Instruments
Date:7/28/2008

lHand(R) High Dexterity (HD) Instruments for Minimally Invasive Surgery

RealHand HD instruments are the very first full range of motion hand-held laparoscopic instruments. RealHand technology is designed to mirror the surgeon's hand direction with the added benefit of tactile feedback. As such, when the surgeon's hand moves in one direction, the instrument tip exactly follows.

Unlike standard laparoscopic instrumentation, RealHand offers complete 7 degrees of freedom of movement in a hand-held instrument and with no need for additional hardware. Moreover, RealHand will enable surgeons to perform more difficult maneuvers that otherwise cannot be completed with traditional rigid instruments. RealHand HD instruments make it easy to actively manipulate and complete tasks regardless of whether the instrument is positioned over, under, or around structures.

RealHand HD instruments provide for greater dexterity and control around critical structures and vasculature. The increase in range of motion is

leading the way in the development of new surgical approaches and techniques. RealHand instruments have received FDA 510(k) clearance.

About Novare Surgical Systems

Based in Cupertino, Calif., Novare Surgical Systems was originally founded in 1999. RealHand was developed entirely at Novare Surgical and represents a shift in the company's focus toward devices for minimally invasive surgery. For more information, visit the company's web site at http://www.novaresurgical.com.


'/>"/>
SOURCE Novare Surgical Systems Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)..., , LOVELAND, Colo., Nov. 19 /PRNewswire-F...ance its customers, experience, Heska Corporation ...ced today the launch of its new and improved websi...nths of analysis, design and programming to align ...rategic objectives. ,, (Logo: http://www.new...
(Date:11/19/2009)..., , MOUNTAIN VIEW, Calif., Nov. 19 /PRNewswi...daq: ALXA ) announced today that its corporate pr...nual Piper Jaffray Health Care Conference on Wedne... The presentation will be webcast from The New Yor...y Thomas B. King, Alexza President and CEO. ,...
(Date:11/19/2009)..., , ABBOTT PARK, Ill., Nov. 19 /PRNewswire-...bott (NYSE: ABT ) as one of its Most Admired Cor... The Deal honored Abbott as its Most Admired De...trategic use of acquisitions and divestitures sinc... has reshaped its business portfolio with a focus ...
Breaking Medicine Technology:Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3New Clues to Race Gap in Breast Cancer Outcomes 50984 1New Clues to Race Gap in Breast Cancer Outcomes 50984 2New Clues to Race Gap in Breast Cancer Outcomes 50984 3Video 3A Perot Systems Unveils Series of Healthcare Video Case Studies 50979 1Video 3A Perot Systems Unveils Series of Healthcare Video Case Studies 50979 2International conference on reproductive science to be held in Pittsburgh July 18 22 50975 1International conference on reproductive science to be held in Pittsburgh July 18 22 50975 2
...racts highlight VELCADE efficacy in broad range,of...GE, Mass., June 19, 2007 /PRNewswire-FirstCall/ --...that data for,VELCADE, the market leading therapy ...s with previously treated multiple myeloma,(MM), w...oma,Workshop (IMW) in Kos, Greece, June 25-30, 200...
... 2007 /PRNewswire-FirstCall/ -- Vical,Incorporated...s MG,Inc. reported positive results following int...o complete a Phase 3 trial of an,angiogenesis prod...y. Based on the findings that the primary efficacy...istical,significance and that there were no major ...
Other Medicine Technology:Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 2Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 3Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 4Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 5Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 6Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 7Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 8Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 2Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 3Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 4Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 5
(Date:11/21/2009)...YORK, Nov. 21 Milvia Lopez, by her...y, recently filed suit, in Supreme Court, New York...t alleges that while Ms. Lopez underwent a routine...NCENT,S HOSPITAL , doctors used an HIV infected sc...eges that several hours after being discharged fro...
(Date:11/21/2009)... Innovative medical apparel company launc... San Clemente, Calif. (PRWEB...akthrough medical apparel, today announced the lau...t Medica 2009, a leading international trade fair ...ny. Medelita inaugurates its men,s collection with...
(Date:11/20/2009)...ering Neurologist Closer to Understanding Brain Wi...swire-USNewswire/ -- Dr. Jeremy Schmahmann, Profes...rologist at the Massachusetts General Hospital in ...boratory,s research on the new field of study call...undation. ,, Dr. Schmahmann is an award-winning...
(Date:11/20/2009)... Senators and Congressmen in Competitive ... Health Care Vote , Washi...d congressmen running for re-election next year in...Charlie Cook, may come to regret voting for House ...ording to a breaking Zogby International/ O’...
(Date:11/20/2009)...ON-SALEM, N.C., Nov. 20 ...sion to redefine what it means to be "happy" durin...or with a specialty in family counseling and chair...iversity, Gladding says research shows that it is ...ss and even depression during the holidays. ,, ...
Breaking Medicine News(10 mins):Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Why Holidays Don't Have To Be 'Happy' 2
...,s first phase one FDA-approved clinical trial usi... will be conducted by a team of University of Lou...first time, patients with advanced heart disease w...,s own cardiac tissue. During surgery, a small pie...
...armatel Fresenius Kabi Pty Ltd, one of Australia,s...l companies, has chosen the RIVA System (Robotic I...IV syringes and bags - from Intelligent Hospital S...tem and Pharmatel Fresenius Kabi,s continued inves...
...eon Inc. (Nasdaq:, EMAG ), a leader in enterprise...als and health care networks, announced today that... Inc. (OTC Bulletin Board: HSSO) that it does not,...r was,scheduled to close today, February 11, 2009,...
... Prevention Through Screenings , ...What better time than February, National Cancer Pr...ealth is in their own hands? ZocDoc, the service t...nth. Now more than ever, New Yorkers are able to m...
...able someone is to have compassion for others , ...es may play a role in a person,s ability to empath...ice. , Researchers trained highly social mice to i...train of mice that were less social didn,t make th...
...s as Medicare-negotiated drug pricing or a ,nation...Y, Feb. 11 (HealthDay News) -- A broad swath of Am...ed overhaul of the U.S. health care system, especi...nge, a new Harris Interactive/HealthDay poll fin...
Other Medicine News:Health News:World's First Cardiac Adult Stem Cell Trial to Take Place in Louisville 2Health News:Australia's Leading Oncology Drug Compounder Chooses RIVA System 2Health News:Emageon Provides Update Regarding Merger Transaction 2Health News:Emageon Provides Update Regarding Merger Transaction 3Health News:ZocDoc Joins the Fight Against Cancer 2Health News:Empathy Might Be in the Genes 2Health News:Poll Shows Strong Support for Obama Health Care Reforms 2Health News:Poll Shows Strong Support for Obama Health Care Reforms 3Health News:Poll Shows Strong Support for Obama Health Care Reforms 4Health News:Poll Shows Strong Support for Obama Health Care Reforms 5
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products: